Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVS CVS Health	$65.79 +1.5%	$58.07	$43.56 ▼ $80.75	$82.95B	0.53	11.67 million shs	7.69 million shs
WBA Walgreens Boots Alliance	$11.26 +0.5%	$10.79	$8.08 ▼ $22.05	$9.73B	0.62	20.54 million shs	17.38 million shs
XLV Health Care Select Sector SPDR Fund	$143.83 -0.5%	$145.05	$135.95 ▼ $159.64	$37.49B	0.69	8.97 million shs	8.04 million shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVS CVS Health	+1.41%	+0.96%	+19.59%	+33.26%	-12.37%
WBA Walgreens Boots Alliance	+0.54%	+6.23%	+20.30%	+8.37%	-46.51%
XLV Health Care Select Sector SPDR Fund	-0.53%	-3.64%	-1.51%	+1.99%	-1.80%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CVS CVS Health	4.9383 of 5 stars	2.5	5.0	3.3	3.9	2.8	3.3	3.1
WBA Walgreens Boots Alliance	3.5822 of 5 stars	1.9	4.0	2.5	2.3	2.4	1.7	0.6
XLV Health Care Select Sector SPDR Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CVS CVS Health	2.90	Moderate Buy	$69.82	6.13% Upside
WBA Walgreens Boots Alliance	1.86	Reduce	$11.54	2.50% Upside
XLV Health Care Select Sector SPDR Fund	2.76	Moderate Buy	$143.83	N/A

Current Analyst Ratings Breakdown

Latest WBA, CVS, and XLV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
2/28/2025	WBA Walgreens Boots Alliance	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold ➝ Sell	$11.00 ➝ $9.00
2/24/2025	WBA Walgreens Boots Alliance	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
2/18/2025	CVS CVS Health	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$77.00
2/18/2025	CVS CVS Health	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$80.00 ➝ $81.00
2/13/2025	CVS CVS Health	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$68.00 ➝ $73.00
2/13/2025	CVS CVS Health	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$60.00 ➝ $76.00
2/13/2025	CVS CVS Health	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$71.00 ➝ $73.00
2/13/2025	CVS CVS Health	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$55.00 ➝ $75.00
2/12/2025	CVS CVS Health	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
2/12/2025	CVS CVS Health	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Overweight
2/11/2025	CVS CVS Health	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Market Perform ➝ Market Perform	$51.00 ➝ $55.00

(Data available from 3/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CVS CVS Health	$372.81B	0.22	$9.19 per share	7.16	$60.06 per share	1.10
WBA Walgreens Boots Alliance	$150.41B	0.06	$6.15 per share	1.83	$13.91 per share	0.81
XLV Health Care Select Sector SPDR Fund	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CVS CVS Health	$4.61B	$3.66	17.98	9.72	0.98	1.24%	9.11%	2.71%	5/7/2025 (Estimated)
WBA Walgreens Boots Alliance	-$8.64B	-$10.24	N/A	7.71	1.31	-5.87%	17.61%	2.89%	3/27/2025 (Estimated)
XLV Health Care Select Sector SPDR Fund	N/A	N/A	32.25	∞	N/A	N/A	N/A	N/A	N/A

Latest WBA, CVS, and XLV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
3/27/2025	N/A	WBA Walgreens Boots Alliance	$0.53	N/A	N/A	N/A	$37.90 billion	N/A
2/12/2025	Q4 2024	CVS CVS Health	$0.89	$1.19	+$0.30	$1.30	$96.90 billion	N/A
1/10/2025	Q1 25	WBA Walgreens Boots Alliance	$0.38	$0.51	+$0.13	-$0.31	$37.40 billion	$39.50 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CVS CVS Health	$2.66	4.04%	+9.97%	72.68%	N/A
WBA Walgreens Boots Alliance	$1.00	8.88%	-19.12%	N/A	N/A
XLV Health Care Select Sector SPDR Fund	$1.99	1.38%	N/A	N/A	N/A

Latest WBA, CVS, and XLV Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
1/3/2025	CVS CVS Health	quarterly	$0.6650	6.02%	1/23/2025	1/23/2025	2/3/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CVS CVS Health	0.80	0.81	0.60
WBA Walgreens Boots Alliance	0.68	0.64	0.30
XLV Health Care Select Sector SPDR Fund	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CVS CVS Health	80.66%
WBA Walgreens Boots Alliance	58.59%
XLV Health Care Select Sector SPDR Fund	N/A

Insider Ownership

Company	Insider Ownership
CVS CVS Health	0.24%
WBA Walgreens Boots Alliance	17.50%
XLV Health Care Select Sector SPDR Fund	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CVS CVS Health	300,000	1.26 billion	1.26 billion	Optionable
WBA Walgreens Boots Alliance	312,000	864.15 million	712.93 million	Optionable
XLV Health Care Select Sector SPDR Fund	N/A	260.67 million	N/A	Not Optionable

WBA, CVS, and XLV Headlines

Recent News About These Companies

Merck and 8 More Healthcare Stocks for Nervous Dividend Investors

March 13 at 5:12 AM | msn.com

Select Sector SPDR ETFs: Strategic Investment with Sector-Specific Allocations

March 12 at 9:11 AM | finance.yahoo.com

Recession Fears Looming? Secure Your Portfolio With These ETFs

March 11 at 5:46 PM | zacks.com

Health Care Sector Trying to Bounce Back

March 6, 2025 | theglobeandmail.com

Shifting Tides in Leadership: Markets Play Defense

March 6, 2025 | etftrends.com

Time for Defensive Sector ETFs?

February 27, 2025 | zacks.com

Healthcare best performing sector as market angst builds

February 25, 2025 | marketwatch.com

Healthcare Stocks Should Be Hurting. How the Sector Became This Year’s Top Performer.

February 25, 2025 | msn.com

Health Care Has Been a Top Sector

February 22, 2025 | finance.yahoo.com

What Top-Performing Healthcare Funds Are Buying Now

February 19, 2025 | msn.com

Final Trade: FWONK, XLV, MSFT, PEP

February 13, 2025 | youtube.com

18 out of 21 healthcare companies beat profit estimates this week- Earnings scorecard

February 8, 2025 | msn.com

Financials, Health Care Sectors Leading U.S. Stocks Higher In 2025

February 7, 2025 | seekingalpha.com

Stock Market Rotation: To Healthcare (XLV), Then Biotechnology (IBB)

February 6, 2025 | seeitmarket.com

Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?

February 4, 2025 | zacks.com

Can Health Care ETFs Aid Your Portfolio?

February 3, 2025 | etftrends.com

XLV: With Relative Strength In January And Compelling Valuation, Health Care Earnings On Tap

February 1, 2025 | seekingalpha.com

Are healthcare stocks on the rebound?

February 1, 2025 | msn.com

XLV: Buy Diversity And Growth

January 31, 2025 | seekingalpha.com

Retirement Stock Portfolio: 10 Healthcare Stocks to Buy

January 28, 2025 | msn.com

S&P 500 Earnings Set to Shine: January's Critical Market Test (XLV)

December 27, 2024 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Price Targets on NVIDIA Rise in Front of Earnings
By Sarah Horvath | February 24, 2025
View Price Targets on NVIDIA Rise in Front of Earnings
Warren Buffett Swaps VOO for This Reliable Dividend Stock
By Sarah Horvath | March 7, 2025
View Warren Buffett Swaps VOO for This Reliable Dividend Stock
Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet
By Jea Yu | March 11, 2025
View Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet
CVS Health: Earnings Beat Ignites Stock Rally
By Jeffrey Neal Johnson | February 13, 2025
View CVS Health: Earnings Beat Ignites Stock Rally
3 Beaten Down Healthcare Stocks Recovering in 2025
By Jea Yu | February 24, 2025
View 3 Beaten Down Healthcare Stocks Recovering in 2025

WBA, CVS, and XLV Company Descriptions

CVS Health NYSE:CVS

$65.79 +0.95 (+1.47%)

Closing price 03/13/2025 03:59 PM Eastern

Extended Trading

$65.93 +0.14 (+0.21%)

As of 08:03 AM Eastern

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Walgreens Boots Alliance NASDAQ:WBA

$11.26 +0.06 (+0.54%)

Closing price 03/13/2025 04:00 PM Eastern

Extended Trading

$11.28 +0.02 (+0.13%)

As of 08:03 AM Eastern

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

Health Care Select Sector SPDR Fund NYSEARCA:XLV

$143.83 -0.77 (-0.53%)

Closing price 03/13/2025 04:10 PM Eastern

Extended Trading

$144.30 +0.47 (+0.33%)

As of 08:03 AM Eastern

Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time